AGER and cancer: Activation of the HMGB1-RAGE signaling axis activates MAPK pathways, inducing Nuclear Factor-κB (NF-κB) activity that is ultimately linked to inflammatory response and cancer cell proliferation, as well as tumor invasiveness [18].